<<< Back to Statistics

Interactions with a minimum Score 2.5

Key
Databases
Other databases reporting interaction:

|< Start

<<< Previous

381

382

383

384

385

386

387

388

389

390

Next >>>

End >|

Protein 1 (?)Protein 1 DescriptionProtein 2 (?)Protein 2 Description Score (?) Evidence (?) Database (?)
TYRO3 TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor LCK LCK: Proto-oncogene tyrosine-protein kinase LCK 13.200 Evidence
SYK SYK: Tyrosine-protein kinase SYK TYRO3 TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor 13.200 Evidence
SH2D1A SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A TEK TEK, TIE2: Angiopoietin-1 receptor precursor 13.200 Evidence
SMAD2 SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 MLLT7 IPI00654651 13.2 Evidence
FOXO1A FOXO1A, FKHR: Forkhead box protein O1A GCN5L2 GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 13.2 Evidence
GNA12 GNA12: Guanine nucleotide-binding protein alpha-12 subunit GRM1 GRM1, GPRC1A, MGLUR1: Metabotropic glutamate receptor 1 precursor 13.2 Evidence
DAB2 DAB2, DOC2: Disabled homolog 2 CBLB CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B 13.2 Evidence
LIMK1 LIMK1, LIMK: LIM domain kinase 1 SNF1LK2 SNF1LK2, KIAA0781, QIK: Serine/threonine-protein kinase SNF1-like kinase 2 13.2 Evidence
GSK3A GSK3A: Glycogen synthase kinase-3 alpha TIAM1 TIAM1: T-lymphoma invasion and metastasis-inducing protein 1 13.2 Evidence
PRKCI PRKCI, DXS1179E: Protein kinase C iota type PRKCZ PRKCZ, PKC2: Protein kinase C zeta type 13.2 Evidence
MAPK1 MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 STMN2 STMN2, SCG10, SCGN10: Stathmin-2 13.2 Evidence
MAPK3 MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 BTK BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK 13.2 Evidence
MAPK3 MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 SYK SYK: Tyrosine-protein kinase SYK 13.2 Evidence
CCND1 CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 BRCA1 BRCA1, RNF53: Breast cancer type 1 susceptibility protein 13.2 Evidence O
CBL CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL PRKCE PRKCE, PKCE: Protein kinase C epsilon type 13.2 Evidence
CBL CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL GSK3A GSK3A: Glycogen synthase kinase-3 alpha 13.2 Evidence
OSBP OSBP, OSBP1: Oxysterol-binding protein 1 RIN1 RIN1: Ras and Rab interactor 1 13.2 Evidence
ATF1 ATF1: Cyclic AMP-dependent transcription factor ATF-1 GCN5L2 GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 13.2 Evidence
ATF1 ATF1: Cyclic AMP-dependent transcription factor ATF-1 MAPK3 MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 13.2 Evidence
VAV1 VAV1, VAV: Proto-oncogene vav MAPK3 MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 13.2 Evidence
VIL2 IPI00479359 GSK3A GSK3A: Glycogen synthase kinase-3 alpha 13.2 Evidence
VDR VDR, NR1I1: Vitamin D3 receptor GCN5L2 GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 13.2 Evidence
FGR FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR CDK2 CDK2: Cell division protein kinase 2 13.2 Evidence
ERBB2 ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor KIT KIT: Mast/stem cell growth factor receptor precursor 13.2 Evidence
PAK4 PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 SOS1 SOS1: Son of sevenless homolog 1 13.2 Evidence

|< Start

<<< Previous

381

382

383

384

385

386

387

388

389

390

Next >>>

End >|


Key to Databases

  1. - BIND
  2. - DIP
  3. - HPRD
  4. O - OPHID